Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06906380
A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies
Sponsor: ARCE Therapeutics, Inc.
View on ClinicalTrials.gov
Summary
This study will evaluate the long-term safety of ARD103 cellular therapies
Official title: A Long-term Follow-up Study of Patients Enrolled in ARD103_ARCE-CL-P-001 Phase 1/2 Study and Treated With ARD103 CAR-T Cell Therapies
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
49
Start Date
2026-03-15
Completion Date
2040-10-31
Last Updated
2025-12-08
Healthy Volunteers
No
Conditions
Interventions
OTHER
Non interventional study
Non Intervention, an observation LTFU study
Locations (3)
Novant Health Cancer Institute
Charlotte, North Carolina, United States
Novant Health Cancer Institute
Winston-Salem, North Carolina, United States
MD Anderson Cancer Center
Houston, Texas, United States